Passage Bio Inc (NASDAQ: PASG) is 5.80% higher on its value in year-to-date trading and has touched a low of $0.45 and a high of $1.79 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PASG stock was last observed hovering at around $0.60 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.60, the stock is -9.42% and -11.47% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.23 million and changing 0.00% at the moment leaves the stock -31.23% off its SMA200. PASG registered -34.79% loss for a year compared to 6-month loss of -32.59%. The firm has a 50-day simple moving average (SMA 50) of $0.67772 and a 200-day simple moving average (SMA200) of $0.87249.
The stock witnessed a -16.90% gain in the last 1 month and extending the period to 3 months gives it a 1.54%, and is -10.45% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.52% over the week and 14.20% over the month.
Passage Bio Inc (PASG) has around 58 employees, a market worth around $37.06M and $0.00M in sales. Distance from 52-week low is 33.04% and -66.48% from its 52-week high. The company has generated returns on investments over the last 12 months (-72.57%).
The EPS is expected to grow by 47.04% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Passage Bio Inc (PASG) Top Institutional Holders
53.0 institutions hold shares in Passage Bio Inc (PASG), with institutional investors hold 59.98% of the company’s shares. The shares outstanding are 61.77M, and float is at 51.70M with Short Float at 7.46%. Institutions hold 59.68% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 10.12 million shares valued at $8.04 million. The investor’s holdings represent 17.9847% of the PASG Shares outstanding. As of 2024-06-30, the second largest holder is VESTAL POINT CAPITAL, LP with 6.05 million shares valued at $4.81 million to account for 10.7504 of the shares outstanding. The other top investors are LYNX1 CAPITAL MANAGEMENT LP which holds 5.06 million shares representing 8.9841% and valued at over $4.02 million, while VERSANT VENTURE MANAGEMENT, LLC holds 7.1523 of the shares totaling 4.03 million with a market value of $3.2 million.
Passage Bio Inc (PASG) Insider Activity
The most recent transaction is an insider sale by ORBIMED ADVISORS LLC, the company’s 10% Owner. SEC filings show that ORBIMED ADVISORS LLC sold 126,209 shares of the company’s common stock on Jan 10 ’25 at a price of $0.66 per share for a total of $83298.0. Following the sale, the insider now owns 7.13 million shares.
Passage Bio Inc disclosed in a document filed with the SEC on Jan 14 ’25 that ORBIMED ADVISORS LLC (10% Owner) sold a total of 79,024 shares of the company’s common stock. The trade occurred on Jan 14 ’25 and was made at $0.60 per share for $47414.0. Following the transaction, the insider now directly holds 7.03 million shares of the PASG stock.
Still, SEC filings show that on Jan 13 ’25, ORBIMED ADVISORS LLC (10% Owner) disposed off 17,986 shares at an average price of $0.64 for $11511.0. The insider now directly holds 7,113,650 shares of Passage Bio Inc (PASG).
